GGrantIndex
Sort

23,748 grants matching melanoma

PAX3 pathways in melanoma

$366,114
Deborah Lang · Boston University Medical Campus · R01 · FY2019 · CA

Molecular connections among UV exposure, red hair, nevi and melanoma

$366,114
Rutao Cui · Boston University Medical Campus · R01 · FY2019 · CA

A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.

$366,076
David E Fisher · Massachusetts General Hospital · R01 · FY2022 · CA

DNA and protein reactions of NO', ONOO-, and reactive species produced by phagocy

$366,071
Peter C Dedon · Massachusetts Institute Of Technology · P01 · FY2010 · CA

Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy

$366,024
Caius Gabriel Radu · California Institute Of Technology · U54 · FY2011 · CA

Collaborative Research: Ultrasensitive Cancer Biomarker Detection on Biophotonic Chips

$366,016
Holger Schmidt · University Of California-Santa Cruz · · FY2012 · ENG

Replication fork remodeling and genomic stability

$366,000
Alberto Ciccia · Columbia University Health Sciences · R01 · FY2020 · CA

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$366,000
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$366,000
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Replication fork remodeling and genomic stability

$366,000
Alberto Ciccia · Columbia University Health Sciences · R01 · FY2018 · CA

Molecular mechanisms of BRAF inhibitor induced UPR and autophagy

$366,000
Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2016 · CA

Merkel cell polyomavirus infection, DNA damage response and cancer

$366,000
Jianxin You · University Of Pennsylvania · R01 · FY2015 · CA

Molecular mechanisms of BRAF inhibitor induced UPR and autophagy

$366,000
Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2015 · CA

Fgl-2 targeted therapy for reversing multi-modality immune suppression

$366,000
Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA

Molecular mechanisms of BRAF inhibitor induced UPR and autophagy

$366,000
Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2017 · CA

A novel pathway to overcome resistance to immunotherapy in melanoma

$366,000
Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2024 · CA

Fgl-2 targeted therapy for reversing multi-modality immune suppression

$366,000
Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA

Merkel cell polyomavirus infection, DNA damage response and cancer

$366,000
Jianxin You · University Of Pennsylvania · R01 · FY2016 · CA

Merkel cell polyomavirus infection, DNA damage response and cancer

$366,000
Jianxin You · University Of Pennsylvania · R01 · FY2018 · CA

Merkel cell polyomavirus infection, DNA damage response and cancer

$366,000
Jianxin You · University Of Pennsylvania · R01 · FY2017 · CA

A novel pathway to overcome resistance to immunotherapy in melanoma

$366,000
Diana Nora Vaz Saleiro · Northwestern University At Chicago · R01 · FY2025 · CA

Fgl-2 targeted therapy for reversing multi-modality immune suppression

$366,000
Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA

Molecular mechanisms of BRAF inhibitor induced UPR and autophagy

$366,000
Ravi K Amaravadi · University Of Pennsylvania · R01 · FY2018 · CA

Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma

$366,000
Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA

Developmental Funds

$365,895
Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · P30 · FY2017 · CA